

05 Jan 2026
// BUSINESSWIRE
https://www.businesswire.com/news/home/20260105450851/en/Dechra-Announces-FDA-Approval-of-Zygolide-pergolide-tablets-for-the-Control-of-Clinical-Signs-Associated-with-Pituitary-Pars-Intermedia-Dysfunction-Equine-Cushings-Disease-in-Horses